Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study-Reference-Cited by-同舟云学术

Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

Published:2019-08 Issue:8 Volume:20 Page:1124-1135
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Banerji Udai,van Herpen Carla M L,Saura Cristina,Thistlethwaite Fiona,Lord Simon,Moreno Victor,Macpherson Iain R,Boni Valentina,Rolfo Christian,de Vries Elisabeth G E,Rottey Sylvie,Geenen Jill,Eskens Ferry,Gil-Martin Marta,Mommers Ellen C,Koper Norbert P,Aftimos Philippe

Funder

National Institute of Health Research award

Publisher

Elsevier BV

Subject

Oncology

Reference25 articles.

1. HER2 expression status in diverse cancers; review of results from 37,992 patients;Yan;Cancer Metastasis Rev,2015

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

4. Emerging drugs targeting human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer;Awada;Expert Opin Emerg Drugs,2016

5. HER2-positive breast cancer: current and new therapeutic strategies;Escrivá-de-Romaní;Breast,2018

Cited by 406 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI-based machine learning radiomics for prediction of HER2 expression status in breast invasive ductal carcinoma;European Journal of Radiology Open;2024-12

2. Dry eye disease adverse reaction of pharmacological treatment for early-stage breast cancer;The Ocular Surface;2024-10

3. Landscape of HER2-low breast cancer: Insights from a six-year study on prevalence and clinicopathological characteristics;Annals of Diagnostic Pathology;2024-10

4. Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas;Cancers;2024-09-13

5. Locally advanced and metastatic endometrial cancer: Current and emerging therapies;Cancer Treatment Reviews;2024-09